Evidence map›Paper›PMID 41047139›Full record

ArticleNucleic acids research2025

High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS.

Laura Christian Resly, Alan L Tubbs, Alexander J Vogel, Jo Ann Hux, Ian A MacDonald, Jason Harris, Adam Mischler, Ginger H Tomberlin, Kathryn S Evans, Rhese Thompson and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Delivery platforms forFrontiers in immunology · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Laura Christian ReslyPrecision BioSciences, Inc. Durham, NC, United States.
Alan L TubbsPrecision BioSciences, Inc. Durham, NC, United States.
Alexander J VogelPrecision BioSciences, Inc. Durham, NC, United States.
Jo Ann HuxPrecision BioSciences, Inc. Durham, NC, United States.
Ian A MacDonaldPrecision BioSciences, Inc. Durham, NC, United States.
Jason HarrisPrecision BioSciences, Inc. Durham, NC, United States.
Adam MischlerPrecision BioSciences, Inc. Durham, NC, United States.
Ginger H TomberlinPrecision BioSciences, Inc. Durham, NC, United States.
Kathryn S EvansPrecision BioSciences, Inc. Durham, NC, United States.
Rhese ThompsonPrecision BioSciences, Inc. Durham, NC, United States.
Jeffrey SunmanPrecision BioSciences, Inc. Durham, NC, United States.
Janel LapePrecision BioSciences, Inc. Durham, NC, United States.
J Jeff SmithPrecision BioSciences, Inc. Durham, NC, United States.
Aaron J MartinPrecision BioSciences, Inc. Durham, NC, United States.ORCID 0000-0003-2336-3579

Funding

Precision BioSciences
6 · The paper itself

Abstract

Several gene editing tools have entered the clinic, representing varied options for eliminating or correcting mutations. Although gene editing by homologous recombination (HR) can potentially accomplish any type of gene edit (insertions, deletions, and replacements), as the outcome is defined by a recombinant repair template, gene editing enzymes that support efficient HR are rare. ARCUS nucleases, engineered from the homing endonuclease I-CreI, have programmable sequence specificity and support precise, high-frequency transgene insertion. In this study, we demonstrate that the 3' overhangs that ARCUS nucleases generate when cutting DNA are key to triggering high rates of HR. We show that a single editor can be used to accomplish the full range of currently understood DNA editing approaches, allowing all combinations of single base changes, introducing small, specific deletions, small and large insertions, and the ability to replace large segments of genomic DNA with efficiencies ranging from 60% to 90% in lymphocytes. ARCUS also supports precise, efficient insertion (30%-40%) in noncycling hepatocytes via nonclassical HR pathways. Collectively, this work characterizes a flexible and efficient gene insertion system for potential therapeutic use.

Indexed as

EndonucleasesGenome, HumanHomologous RecombinationBase SequenceCells, CulturedDNADNA RepairGene EditingHepatocytesHumansMutagenesis, InsertionalProtein EngineeringDNAEndonucleases

Identifiers

PMID41047139
PMCPMC12497482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.